▼ -13.25% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for Invesque in the last 3 months. The average price target is $2.75, with a high forecast of $3.00 and a low forecast of $2.50. The average price target represents a -13.25% upside from the last price of $3.17.
The current consensus among 2 polled investment analysts is to hold stock in Invesque.
Invesque Inc. operates as a real estate investment company in Canada and the United States. Its portfolio of investments include independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2021, it owned a portfolio of 107 properties, including 72 assisted living and memory care facilities, 17 skilled nursing facilities, 13 transitional care properties, and 4 medical office buildings in the United States; and 15 properties comprised 11 medical office buildings, and 4 seniors housing and care facilities in Canada. The company was formerly known as Mainstreet Health Investments Inc. and changed its name to Invesque Inc. in January 2018. Invesque Inc. is headquartered in Toronto, Canada.